The genomic landscape of this exclusively Romanian NSCLC cohort was broadly consistent with findings from larger European studies but showed a relatively high prevalence of KRAS p.G12C mutations and a notable incidence of FGFR1/FGFR3 amplifications. Here, KRAS is linked to non-small cell lung carcinoma.